Brian Quebbemann, M.D., F.A.C.S., F.A.S.M.B.S., is an authority on metabolic surgery. With 25+ years of experience, Dr. Quebbemann has helped over 8,000 patients achieve dramatic weight loss and improve their metabolic health. He has performed numerous metabolic procedures to resolve diabetes and other health conditions and recently invented the S.L.I.M.M.S.™ Procedure now an investigational surgery designed to improve diabetes, metabolic syndrome, and excess weight. Dr. Quebbemann stands as one of the top experts in metabolic surgery.
Gastric bypass and sleeve have been shown to significantly improve type-2 diabetes, and even bring the disease into remission. Even individuals with a lower BMI who have never considered bariatric surgery as an option could resolve their diabetes using these procedures.
Diabetes carries significant health risks, including nerve damage, eye and kidney damage, and an increased risk of heart attack and stroke. Managing diabetes is crucial for long-term health. And growing medical consensus is that for many individuals, the risk of untreated diabetes outweighs the lower risks of bariatric surgery. Endocrinology and diabetes societies including the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) are beginning to recommend bariatric surgery as a treatment option for some patients.
Diabetes is a metabolic disease, meaning the way the body metabolizes food is the root of the problem.
Recent studies have shown that gastric bypass alters the way hormones from your small intestines work in the absorption of food. Gastric bypass also changes how your body manages the level of sugar in your bloodstream. This means the beneficial effects on diabetes can sometimes be almost immediate.
Early surgery increases the chances for long-term remission, with all the long-term health benefits that come with it. Metabolic surgery to treat Type-2 Diabetes associated with obesity has been endorsed by 45 worldwide medical and scientific societies*.
* Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations Diabetes Care 2016;39:861–877 | DOI: 10.2337/dc16-0236